Communiqués NeurAxis, Inc.

Actions

NRXS

US64134X2018

Marché Fermé - Nyse Autres places de cotation 22:10:00 18/06/2024			Varia. 5j.	Varia. 1 janv.
2,8 ^USD	+0,36%		-6,04%	+4,87%

07/06	NeurAxis soumet à la FDA une demande d'extension de l'étiquette IB-Stim	MT
22/05	Neuraxis, Inc. fournit des prévisions de résultats pour la fin de l'année 2024 et l'année 2025	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure	07/06	GL
NeurAxis Reports First Quarter 2024 Financial Results	22/05	GL
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	21/05	GL
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida	16/05	GL
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida	16/05	AQ
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024	15/05	GL
NeurAxis Announces New Medical Policy Coverage in North Dakota	23/04	GL
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	09/04	GL
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024	01/04	GL
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry	27/03	GL
NeurAxis Announces Highmark BCBS Policy Coverage	11/03	GL
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage	04/03	GL
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	27/02	GL
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer	31/01	GL
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer	31/01	AQ
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer	20/12	GL
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer	20/12	AQ
NeurAxis Reports Third Quarter 2023 Financial Results	20/11	GL
NeurAxis Announces CareFirst BCBS Policy Coverage	15/11	GL
NeurAxis Announces CareFirst BCBS Policy Coverage	15/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NeurAxis, Inc.

Actions

NRXS

US64134X2018

Communiqués

Filtres